載入...
Biosimilar Insulins: How Similar is Similar?
Biosimilar insulins (BIs) are viewed as commercially attractive products by a number of companies. In order to obtain approval in the European Union or the United States, where there is not a single BI currently on the market, a manufacturer needs to demonstrate that a given BI has a safety and effi...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Diabetes Technology Society
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3192641/ https://ncbi.nlm.nih.gov/pubmed/21722590 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|